ERBB2 and gastric cancer: Using kits approved by the United States Federal Drug Administration for IHC (HercepTestTM and EGFR pharmDxTM) and FISH (Path VysionTM), we have analyzed EGFR and ERBB2 protein expression and gene status in Chinese gastric cancer patients in order to provide more accurate reference data for future studies in the Chinese population.